InvestorsHub Logo
Followers 46
Posts 4429
Boards Moderated 0
Alias Born 07/26/2010

Re: Rhodey Red post# 12227

Wednesday, 07/30/2014 9:27:17 AM

Wednesday, July 30, 2014 9:27:17 AM

Post# of 15766
Can you explain "scleroderma" in layman terms?

Purified Poloxamer 188 (MST-188)
MST-188 (Mast Therapeutics, Inc.) is an investigational agent with potential utility in a
wide range of diseases that are characterized by impaired blood flow. The active ingredient
in MST-188 is a purified form of poloxamer 188. Research has shown that poloxamer 188
lowers blood viscosity, decreases red blood cell aggregation, and decreases friction between red blood cells and vessel walls to increase microvascular blood flow and decrease cell
injury. While it has mostly been studied as a potential treatment for sickle cell disease, it
may also have potential to treat Scleroderma by reducing red blood cell aggregation,
inflammation, and restoring cell membrane integrity. A Phase 3 study of MST-188 in sickle
cell disease is currently underway (May 2014).
Poloxamer 188 is considered safe and is widely used in many over the counter products
such as toothpaste, laxatives, and mouthwash. The FDA approved it more than 50 years
ago as a therapeutic reagent to reduce viscosity of blood before it is used in transfusions.